“Cardiac Implantable devices aim to treat long term heart conditions such as heart failure. These devices are intended to detect any fluctuations in the cardiac system and rectify it automatically or provide support to organs and tissues. Advancement in technology, growing incidences of cardiovascular diseases such as coronary artery diseases (CAD), arrhythmia and launch of new and innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators (S-ICDs) are some of the key drivers for the growth of this market.
The market will show a significant growth in the next few years and is expected to reach $43.4 billion by 2020 at a CAGR of 12.5%. Advancement in technology, growing incidences of cardiovascular diseases such as coronary artery diseases (CAD), atrial fibrillation and aortic aneurysms and launch of new and innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators (S-ICDs) are some of the key drivers for the growth of this market.
In this report different market aspects are explored with particular focus on key market drivers, challenges, constraints and market landscape. The Global market has been thoroughly analyzed and carefully segmented by geographic locations based on major economic and topographical regions.The market for Cardiac implantable devices is classified into several categories based on types of implantable devices, disease conditions and cardiac procedures. They can be utilized in the diagnosis and treatment of various disease conditions such as Myocardial Ischemia, Cardiac Arrest, Arrhythmia, Acute Myocardial Infarction and many others.
Among cardiac implantable devices, coronary stents devices are generating the largest revenue whereas in future TAVR (Transcatheter Aortic Valve Replacement) valves will capture major market segment.
Major market players are profiled along with company overview, financial status, business strategies, product portfolio, recent trends and developments.
The prominent players profiled in this report are:
Medtronic Inc.,
Boston Scientific Corporation
St. Jude Medical Inc.,
Abbott Vascular Inc.
Edwards Lifesciences Corporation.
The report details current market potential and future market growth in this industry. Overall the report contains the most detailed and in depth segmentation and analysis of the Global Cardiac Implantable Devices Market during the forecast period 2015-2020.”
“1. Cardiac Implant Devices Market Overview
2. Executive Summary
3. Cardiac Implant Devices – Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Patent Analysis
3.2.3. End user profiling
3.2.4. Top 5 Financials Analysis
4. Cardiac Implant Devices – Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Cardiac Implant Devices Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product lifecycle
5.4. Pricing Analysis
6. Cardiac Implant Devices Market– By Devices
6.1. Cardiac Resynchronization Therapy Devices (CRT’S)
6.2. Implantable Cardioverter Defibrillators (ICD’S)
6.3. Implantable Cardiac Pacemakers (ICPs)
6.4. Coronary Stents
6.5. Heart Valve Replacement/Repair Devices
6.6. TAVR (Transcatheter Aortic Valve Replacement) Valves
7. Cardiac Implant Devices Market- By Disease Conditions
7.1. Myocardial Ischemia
7.2. Acute Myocardial Infarction
7.3. Arrhythmias
7.4. Others
8. Cardiac Implant Devices Market Classification- By Procedure
8.1. Cardiac Resynchronization Therapy (CRT)
8.2. Minimally Invasive Heart Surgery
8.3. Open heart surgery
8.4. Angioplasty
8.5. Heart Valve Repair or Replacement
8.6. Others
9. Cardiac Implant Devices Market -Geographic Analysis
9.1. North America
9.1.1. USA
9.1.2. Canada
9.1.3. Mexico
9.1.4. Others
9.2. Europe
9.2.1. France
9.2.2. Germany
9.2.3. Italy
9.2.4. Spain
9.2.5. U.K
9.2.6. Others
9.3. APAC
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. Australia
9.3.5. Others
9.4. ROW
9.4.1. South Africa
9.4.2. Russia
9.4.3. Middle East
9.4.4. Others
10. Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs and Partnerships
11. Company profiles
11.1. Abbott Vascular Inc.
11.2. Medtronic, Inc.
11.3. Biotronik, Inc.
11.4. Bentley InnoMed GmbH
11.5. Elestim-Cardio
11.6. Cardioelectronica GmbH
11.7. Qualimed Innovative Medizinprodukte Gmbh
11.8. Medico S.p.A
11.9. Lepu Medical Technology
11.10. Boston Scientific Corporation
11.11. St. Jude Medical, Inc.
11.12. Edwards Lifesciences Corporation
11.13. Biosensors International Group, Ltd.
11.14. Japan Lifeline Co., Ltd.
11.15. Sorin S.p.A.
11.16. JenaValve Technology Inc.
11.17. Opto Circuits Limited
11.18. Hexacath
11.19. MicroPort Scientific Corporation.
11.20. Cardionovum GmbH
11.21. Alvimedica
11.22. Amaranth Medical
11.23. Stentys SA
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
“”*Financials would be provided on a best efforts basis for private companies””
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer”
“11.1. Abbott Vascular Inc.
11.2. Medtronic, Inc.
11.3. Biotronik, Inc.
11.4. Bentley InnoMed GmbH
11.5. Elestim-Cardio
11.6. Cardioelectronica GmbH
11.7. Qualimed Innovative Medizinprodukte Gmbh
11.8. Medico S.p.A
11.9. Lepu Medical Technology
11.10. Boston Scientific Corporation
11.11. St. Jude Medical, Inc.
11.12. Edwards Lifesciences Corporation
11.13. Biosensors International Group, Ltd.
11.14. Japan Lifeline Co., Ltd.
11.15. Sorin S.p.A.
11.16. JenaValve Technology Inc.
11.17. Opto Circuits Limited
11.18. Hexacath
11.19. MicroPort Scientific Corporation.
11.20. Cardionovum GmbH
11.21. Alvimedica
11.22. Amaranth Medical
11.23. Stentys SA”
